Author

James Clary

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Alessia Tagliavini· 2 shared Alexander K. BergiD· 2 shared Anna M. UptoniD· 2 shared David J. Hermann· 2 shared Sylvie SordelloiD· 2 shared Darren Metcalf· 1 shared Debra Flood· 1 shared Debra L. Hanna· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Alessia Tagliavini

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Stochastic Simulation-Based Approach to Inform Relapsing Mouse Model (RMM) Study Design for Non-Clinical Assessment of Tuberculosis

James Clary, Jessica K. Roberts, Debra L. Hanna, Alessia Tagliavini, Sylvie Sordello, Anna M. Upton, David J. Hermann, Alexander K. Berg

This paper evaluates alternative study designs for relapsing mouse models of tuberculosis to reduce animal use while maintaining accuracy in estimating treatment efficacy.

Antimicrobial Agents and Chemotherapy · Dec 29, 2025Peer-reviewedPharmacology & Toxicology

A modeling-based framework to evaluate forgiveness of TB drug combinations in a BALB/c relapsing mouse model.

Sylvie Sordello, Laure Brock, Alessia Tagliavini, Denise Federico, Xavier Boulenc, Marco Pergher, Emilie Huc‐Claustre, Darren Metcalf, Nicholas D. Walter, Gregory T. Robertson, James Clary, Alexander K. Berg, Khisimuzi E. Mdluli, David J. Hermann, Debra Flood, Anna M. Upton

This study evaluates the forgiveness of TB drug combinations using a mouse model, finding BPaMZ is more forgiving of missed doses than RHZE/RH.

bioRxiv · Aug 7, 2025 · PreprintPharmacology & Toxicology